Forty years of topical beta-blockers

28 February 2020
Volume 21, Issue 1
Independent prescribing

This article reviews the use of topical beta-blockers for the treatment of glaucoma.

Although beta-blockers are no longer first choice for the treatment for glaucoma, they maintain a place in the treatment pathway. This article reviews the history and contemporary use of topical beta-blockers, and considers the range of alternative medical, laser and minimally invasive surgical options for glaucoma.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Join the College today

Related further reading

Independent prescribing in practice

Independent prescribing optometrists can establish a diagnosis and determine clinical management, providing better care to patients, writes Georgina Wintersgill

Independent prescribing

College welcomes government proposed plans to extend range of medicines that optometrists can supply

As part of its 10-Year Health Plan, the government is proposing to extend the range of prescription-only medicines available for optometrists to supply under the medicines exemptions legislation.

Independent prescribing New models of care Policy Workforce

Cover your therapeutic competencies with the College

We have a number of therapeutic points available to IP members struggling to cover their competencies by the end of this year.

Independent prescribing